ArticleMolecular syndromology2026
Genotypic and Phenotypic Characteristics of Turkish Patients with Hereditary Fructose Intolerance.
Article in Molecular syndromology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hereditary fructose intolerance (HFI) is an autosomal recessive inherited metabolic disorder characterized by a deficiency of the fructose-1-phosphate aldolase (aldolase B) enzyme, caused by biallelic pathogenic variants in the Methods: We retrospectively analyzed the demographic, clinical, biochemical, and molecular genetic characteristics of 9 patients from eight unrelated Turkish families diagnosed with HFI over the past 10 years at a single center. Results: Patients with HFI showed an aversion to sugar-containing foods and generally had a favorable prognosis. The most common presenting complaints or reasons for referral to our clinic in this cohort were vomiting, hepatosteatosis, and elevated transaminases. Fructose aversion was present in all patients, representing a protective adaptive behavior rather than a complaint, and was therefore not reported as a symptom. Hypoglycemic syncope was observed in only 1 patient, while no significant hypoglycemia or metabolic acidosis was detected in the others. Urinary reducing substances and urine sugar chromatography were negative, likely due to the avoidance of fructose-containing foods. The p.Ala150Pro and p.Ala175Asp were identified as the most frequent variants. Homozygous variants (87.5%) were more common than compound heterozygous variants (12.5%). Conclusion: Genetic analysis of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.